Fingerprint
Dive into the research topics of 'Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial
Shaji K. Kumar, Martha Q. Lacy, Suzanne R. Hayman, Keith Stewart, Francis K. Buadi, Jacob Allred, Kristina Laumann, Philip R. Greipp, John A. Lust, Morie A. Gertz, Steven R. Zeldenrust, P. Leif Bergsagel, Craig B. Reeder, Thomas E. Witzig, Rafael Fonseca, Stephen J. Russell, Joseph R. Mikhael, David Dingli, S. Vincent Rajkumar, Angela Dispenzieri
Research output: Contribution to journal › Article › peer-review
49
Scopus
citations